Financial statements Biomol-Med
Balance sheet of Biomol-Med
Company age:
Age:
23 y. 7 d.
Share capital:
Share capital:
51 000 PLN
Balance sheet data of BIOMOL-MED
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 600 253,08 | 1 826 058,31 | 1 526 646,80 | 995 790,46 | 578 762,99 | 815 099,39 |
| A. Fixed assets | 529 199,13 | 455 345,24 | 340 173,97 | 225 717,42 | 218 131,29 | 381 424,89 |
| B. Current assets | 1 071 053,95 | 1 345 148,29 | 1 186 472,83 | 770 073,04 | 360 631,70 | 433 674,50 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 600 253,08 | 1 826 058,31 | 1 526 646,80 | 995 790,46 | 578 762,99 | 815 099,39 |
| A. Equity | 1 553 128,75 | 1 691 827,18 | 1 418 520,40 | 874 389,56 | 414 543,90 | 727 816,67 |
| B. Liabilities and provisions for liabilities | 47 124,33 | 134 231,13 | 108 126,40 | 121 400,90 | 164 219,09 | 87 282,72 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | 47 124,33 | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.